Skip to search formSkip to main contentSkip to account menu

Tafamidis meglumine

Known as: D-Glucitol, 1-Deoxy-1-(Methylamino)-, 2-(3,5-Dichlorophenyl)-6-Benzoxazolecarboxylate (1:1), D-Gluco-2,3,4,5,6-Pentahydroxy-N-Methylhexan-1-Aminium 2-(3,5-Dichlorophenyl)Benzoxazole-6-Carboxylate 
A soft gelatin capsule formulation containing the meglumine salt form of tafamidis, a small molecule and pharmacological chaperone with potential… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Transthyretin familial amyloid polyneuropathy (ATTR-FAP) is a fatal hereditary amyloidosis characterized by extracellular… 
2019
2019
Transthyretin amyloid cardiomyopathy (ATTR-CM), is an underdiagnosed, fatal disease caused by the deposition of… 
2019
2019
Ke klinicky relevantnĂ­mu postiĹženĂ­ srdce mohou vĂSst AL (light-chain) amyloidĂlza Ai transthyretinovĂĄ amyloidĂlza (ATTR… 
2018
2018
Tafamidis meglumine, a transthyretin (TTR) stabilizer, is effective in delaying the progression of neuropathy in TTR amyloidosis… 
2018
2018
  • de
  • 2018
  • Corpus ID: 195342867
Es ist ein therapeutischer Durchbruch: Patienten mit kardialer Transthyretin-Amyloidose reduzieren ihr Sterberisiko deutlich… 
2011
2011
  • 2011
  • Corpus ID: 52107192
2009
2009
A new drug candidate has, for the first time, modified disease progression in patients with a rare inherited proteinmisfolding… 
2009
2009
A new drug candidate has, for the first time, modified disease progression in patients with a rare inherited proteinmisfolding…